- Home
- HALO vs GTLB Comparison
HALO vs GTLB Comparison
Compare HALO & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HALO
- GTLB
- Stock Information
- Founded
- HALO 1998
- GTLB 2011
- Country
- HALO United States
- GTLB United States
- Employees
- HALO N/A
- GTLB N/A
- Industry
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- GTLB EDP Services
- Sector
- HALO Health Care
- GTLB Technology
- Exchange
- HALO Nasdaq
- GTLB Nasdaq
- Market Cap
- HALO 7.4B
- GTLB 7.0B
- IPO Year
- HALO N/A
- GTLB 2021
- Fundamental
- Price
- HALO $50.23
- GTLB $53.36
- Analyst Decision
- HALO Buy
- GTLB Strong Buy
- Analyst Count
- HALO 9
- GTLB 23
- Target Price
- HALO $63.78
- GTLB $71.22
- AVG Volume (30 Days)
- HALO 2.6M
- GTLB 2.2M
- Earning Date
- HALO 05-06-2025
- GTLB 06-02-2025
- Dividend Yield
- HALO N/A
- GTLB N/A
- EPS Growth
- HALO 55.40
- GTLB N/A
- EPS
- HALO 3.76
- GTLB N/A
- Revenue
- HALO $1,084,306,000.00
- GTLB $759,249,000.00
- Revenue This Year
- HALO $24.79
- GTLB $26.19
- Revenue Next Year
- HALO $22.65
- GTLB $21.91
- P/E Ratio
- HALO $13.36
- GTLB N/A
- Revenue Growth
- HALO 25.64
- GTLB 30.93
- 52 Week Low
- HALO $41.28
- GTLB $37.90
- 52 Week High
- HALO $70.51
- GTLB $74.18
- Technical
- Relative Strength Index (RSI)
- HALO 34.42
- GTLB 65.91
- Support Level
- HALO $58.38
- GTLB $44.53
- Resistance Level
- HALO $69.94
- GTLB $47.41
- Average True Range (ATR)
- HALO 3.30
- GTLB 1.77
- MACD
- HALO -0.27
- GTLB 1.13
- Stochastic Oscillator
- HALO 9.30
- GTLB 97.59
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.